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Abstract
Evidence that brain edema and aquaporin-4 (AQP4) water channels have roles in experimental binge ethanol-induced
neurodegeneration has stimulated interest in swelling/edema-linked neuroinflammatory pathways leading to oxidative stress.
We report here that neurotoxic binge ethanol exposure produces comparable significant effects in vivo and in vitro on adult rat
brain levels of AQP4 as well as neuroinflammation-linked enzymes: key phospholipase A2 (PLA2) family members and poly
(ADP-ribose) polymerase-1 (PARP-1). In adult male rats, repetitive ethanol intoxication (3 gavages/d for 4 d, ,9 g/kg/d,
achieving blood ethanol levels ,375 mg/dl; ‘‘Majchrowicz’’ model) significantly increased AQP4, Ca+2-dependent PLA2 GIVA
(cPLA2), phospho-cPLA2 GIVA (p-cPLA2), secretory PLA2 GIIA (sPLA2) and PARP-1 in regions incurring extensive
neurodegeneration in this model—hippocampus, entorhinal cortex, and olfactory bulb—but not in two regions typically
lacking neurodamage, frontal cortex and cerebellum. Also, ethanol reduced hippocampal Ca+2-independent PLA2 GVIA
(iPLA2) levels and increased brain ‘‘oxidative stress footprints’’ (4-hydroxynonenal-adducted proteins). For in vitro studies,
organotypic cultures of rat hippocampal-entorhinocortical slices of adult age (,60 d) were ethanol-binged (100 mM or
,450 mg/dl) for 4 d, which augments AQP4 and causes neurodegeneration (Collins et al. 2013). Reproducing the in vivo
results, cPLA2, p-cPLA2, sPLA2 and PARP-1 were significantly elevated while iPLA2 was decreased. Furthermore,
supplementation with docosahexaenoic acid (DHA; 22:6n-3), known to quell AQP4 and neurodegeneration in ethanol-
treated slices, blocked PARP-1 and PLA2 changes while counteracting endogenous DHA reduction and increases in oxidative
stress footprints (3-nitrotyrosinated proteins). Notably, the PARP-1 inhibitor PJ-34 suppressed binge ethanol-dependent
neurodegeneration, indicating PARP upstream involvement. The results with corresponding models support involvement of
AQP4- and PLA2-associated neuroinflammatory pro-oxidative pathways in the neurodamage, with potential regulation by
PARP-1 as well. Furthermore, DHA emerges as an effective inhibitor of these binge ethanol-dependent neuroinflammatory
pathways as well as associated neurodegeneration in adult-age brain.
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Introduction
Alcohol (ethanol) use disorders constitute a major worldwide
cause of health impairment and productivity loss [1,2]. Amidst a
range of organ damage outcomes, chronic ethanol abuse—and
particularly binge-type alcoholism [3,4]—causes neuropathologi-
cal sequelae leading to brain dysfunction and dementia [5]. A
repetitive binge intoxication adult rat model developed by
Majchrowicz nearly 40 years ago to study alcoholic withdrawal
seizures [6] was later shown to have surprisingly regionalized
neurodegeneration in the temporal (particularly entorhinal) cortex
(EC) and the hippocampus (HC) (mainly dentate gyrus granule
cells), as well as olfactory bulb neurons [7,8]. Results indicating the
involvement of oxidative stress but not excitotoxicity [9] in this in
vivo model of acquired neurodegeneration point to neuroinflam-
matory (glial-neuronal) pro-oxidative mechanisms; however, the
detailed pathways remain uncertain. The Majchrowicz adult rat
intoxication model or a variant has been used by a number of
laboratories to examine underlying mechanisms. Apoptosis as a
chief neurodegenerative pathway was ruled out by the absence of
TUNEL staining [10]. Evidence that diuretics such as furosemide
and acetazolamide prevent ethanol-induced elevations in rat brain
water content while reducing or blocking neurodegeneration
indicated that brain edema was important [11,12]. Cellular
edema, a major and often intractable clinical problem that
exacerbates neuropathology in brain ischemia and trauma, thus
might elicit neuroinflammatory processes in binge ethanol abuse.
A further contributor to the neurodamage in this binge model may
well be stress-elevated circulating glucocorticoid (corticosterone),
as recently reported [13]. (However, it is worth noting a paradox
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in that glucocorticoids have well-known edema-resolving effects,
particularly under cerebral acidotic conditions [14]).
Neuroinflammation—brain pro-oxidative processes dependent
on glia acting on neurons—has assumed a more general focus in
alcohol neuropathology studies. While there is considerable
interest in the role of microglial activation, it is unclear in the
above binged rat model whether microglia contribute directly to
neurodegeneration [15,16]. Astroglia could have key roles, since
they are enriched in membrane aquaporin-4 (AQP4) water
channels that mediate glial edema during brain insults [17].
Furthermore, such brain astroglial swelling due to binge ethanol
could promote phospholipid-instigated neuroinflammation—e.g.,
increased phospholipase A2 (PLA2) activities, which release
excessive quantities of arachidonic acid (ARA, 20:4n-6) from
membrane phospholipids [18,19]. ARA can be a major source of
reactive oxygen species (ROS) via autoxidation and its metabolism
to eicosanoid products. Specific families of PLA2 known to
mobilize ARA during brain insults and neuroinflammatory stresses
were the focus of our studies here. Calcium (Ca+2)-dependent
(cytosolic) PLA2 (cPLA2), which has received the most attention
[20]—and particularly the cPLA2 GIVA isoform—was examined.
Small secreted PLA2 (sPLA2) enzymes have gained interest in
neuroinflammatory models [21], among which sPLA2 GIIA
received our focus. In contrast, Ca+2-independent PLA2 (iPLA2)
isoforms may have brain homeostatic roles; we were principally
interested in iPLA2 GVIA, because of its importance in the
turnover of endogenous docosahexaenoic acid (DHA, 22:6n-3)
[22]. Moreover, we were guided by our results from brain regions
of adult rats given moderate rather than high ethanol doses in a
‘‘binge-pattern’’ [23], which showed reduced iPLA2 GVIA and
significantly elevated expression levels of cPLA2 GIVA, sPLA2
GIIA, and AQP4, as well as poly (ADP-ribose) polymerase-1
(PARP-1). PARP-1 is a key nuclear DNA repair enzyme, but when
hyperactivated, it can promote a form of regulated necrosis
(termed parthanatos) by oxidative stress routes involving glial
activation [24,25].
The above neuroinflammation-related enzymes were examined
in the Majchrowicz in vivo intoxication model, in parallel with a
somewhat unique in vitro model, binge ethanol-treated adult-age
rat organotypic hippocampal-entorhinal cortical (HEC) slices in
culture. Organotypic brain slice cultures (typically hippocampal
and only occasionally HEC) have often been used in neurode-
generation studies [26,27], but invariably at adolescent or
developing brain ages. It seemed reasonable that data with
adult-age HEC slice preparations would more reliably correlate
with results from intact adult brain. For example, the adult-age rat
HEC slices incur neurodamage and AQP4 elevations when
subjected to binging that closely approximates the in vivo model
(four successive [overnight] exposures to 100 mM ethanol—a
concentration not unusual in the blood of severe alcoholics [28,29]
that is frequently used in neurodegeneration studies—whereas
developing HEC slice cultures require ,6 exposure days) [30]. At
least with entorhinal cortex, the above suggestion that adult brain
neurons are more susceptible than developing neurons to binge
ethanol-induced neurodegeneration corresponds well with binge
ethanol results in vivo [31]. Since edema is linked at times to
reactive oxygen/nitrogen species, we also assessed the extent of
oxidative stress in the ethanol-binged slices using ‘‘oxidative
footprints’’—levels of 4-hydroxynonenal (4HNE)-adducted and/or
3-nitrotyrosinated (3NT-) proteins. In part, the latter assays were
motivated by indications in other disease conditions involving
brain oxidative stress, e.g., hepatic encephalopathy, that protein
tyrosine nitration is associated with brain edema [32].
An important facet of this study is the investigation of the
neuroprotective effects of DHA against ethanol-dependent brain
damage [30,33]. Endogenous rat brain levels of this essential n-3
unsaturated fatty acid are equal to those of n-6 ARA, but in
contrast to the latter, DHA is often anti-oxidative and anti-
inflammatory rather than pro-inflammatory [34–36]. Depletion of
brain DHA, principally within membrane phosphatidylserine,
could underlie aberrant neuroapoptosis in fetal alcoholism models
[37,38], and dietary DHA can counter the brain oxidative damage
and neurobehavioral deficits of ethanol exposure in utero [39–41].
We find with the ethanol-binged adult-age HEC slice cultures that
endogenous DHA is indeed reduced, and that supplemented DHA
normalizes those levels, reduces oxidative stress, and exerts global
suppression of the above neuroinflammatory proteins. One of
these, PARP-1, may be a crucial regulatory enzyme in a pro-
inflammatory phospholipid-dependent cascade.
Materials and Methods
Materials
Antibodies. AQP4 (sc-20812), cPLA2 IVA (sc-454), ser 505
p-cPLA2 IVA (sc-34391), and glyceraldehyde phosphate dehy-
drogenase (GAPDH, sc-166545) were from Santa Cruz Biotech-
nology, Santa Cruz CA; iPLA2 VIb (07-169) was from Upstate
Biotech, Lake Placid NY; sPLA2 IIA (181055100) was from
BioVendor, Candler NC; PARP-1 (9542s) was from Cell
Signaling, Danvers MA; Anti-3NT-protein (AB7048) was from
Abcam Co., Cambridge MA; and anti-4HNE-adducted protein
(AB5605) was from Millipore Corp., Temecula CA. Secondary
antibodies were from Jackson ImmunoResearch, West Grove PA,
and luminol reagent for immunoblot detection was from Pierce
Chemicals, Rockford IL. DHA was from Cayman Chemicals, Ann
Arbor MI, PJ34 was from Enzo Life Sciences, Farmingdale NY,
and other chemicals/reagents were from Sigma Chemicals, St.
Louis MO.
Animal experiments
These studies were carried out in accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The in
vivo protocol was approved by the Institutional Animal Care and
Use Committee of the University of Kentucky, and all efforts were
made to minimize suffering during treatments and sacrifice. The
in vitro protocol was approved by the Institutional Animal Care
and Use Committee of Loyola University Medical Center, and all
efforts were made to minimize suffering during anesthesia and
sacrifice.
Binge ethanol intoxication in vivo
Adult male SD rats (275–300 g) were subjected to the 4-day
binge intoxication protocol modified from Majchrowicz that has a
well-documented neurodegeneration profile [8,42,43]. The model
mimics the high blood ethanol levels of binge pattern alcoholics
[3]. Rats were provided nutritionally complete liquid diets
containing either ethanol (25%w/v) or isocaloric dextrose in
vanilla Ensure Plus (Abbott Laboratories, Columbus OH) every
8 hr via intragastric gavage (range: 8.3–9.7 g/kg/d). Rats in the
ethanol group received an initial loading dose of 5 g/kg, with
subsequent doses adjusted based on a behavioral intoxication scale
detailed in earlier reports [44,45]. Control rats were given volumes
of diet equal to the average volumes given the ethanol-treated rats.
Water was freely available but not chow. Serum ethanol levels,
which averaged ,375 mg/dl (,82 mM), were ascertained in
blood samples taken 90 min after the 6th ethanol dose using an
Ethanol, Brain Neuroinflammation and DHA
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AM1 Alcohol Analyzer (Analox, London UK) calibrated against a
300 mg/dl external standard. Rats were sacrificed by decapitation
on the morning of the 5th day, 8–10 hr after the last ethanol or
control gavage treatment. Intact brains were quickly removed,
divided in half and quick-frozen in liquid nitrogen. At appropriate
times, brains were thawed on ice and respective brain regions were
taken for protein extraction as described under Immunoblotting.
Adult-age HEC slice cultures
Male Sprague-Dawley rats (Harlan, Indianapolis IN), 4062
days old, were anesthetized with isoflurane and thoroughly
perfused via the intracardiac route with ,150 ml of ice-cold
lactate-Ringer’s solution. When translucent, rat brains were placed
in ice-cold Gey’s buffer solution; the hippocampal-entorhinal
cortical complex was removed and slices (250–300 m) were
prepared using a McIlwain tissue chopper. Slices were carefully
placed on Millipore 0.4 m membrane inserts (2–3 slices/insert),
which were placed in 6-well plates, with each well containing
1.2 ml of MEM media with 25% heat-inactivated horse serum
(HS). Slices were incubated at 32uC and 5% CO2 for the first
48 hr, and media was then changed to 20% heat-inactivated HS,
and slices were transferred to a 37uC incubator (5% CO2).
Cultures were then maintained 17–19 days, with the media
changed every 2–3 days. Slices were monitored visually and those
appearing unusually dark or broken were discarded.
Binge ethanol and DHA treatment of HEC slice cultures
At a brain age of 6063 days, slices in experimental groups were
treated overnight for ,16 h with 100 mM ethanol in MEM/20%
HS for 4 successive nights, media without ethanol for ,8 h during
daylight hours for 3 d and then ,4 h on the 4th day, to permit
slice assays. Control slices were subjected to similar changes
throughout the 4 d period with HS-containing MEM media
without ethanol. Half of experimental and control slices were
treated with DHA (25–50 mM) or PJ34 (10 mM) beginning 4 h
prior to the start of ethanol treatment and throughout both
overnight ethanol/media and daytime media exposures. The
DHA concentrations used, reported to sustain neuronal viability in
primary brain cultures [46], border physiological values for n-3
fatty acids [47]. Slices then were treated as described below with
propidium iodide (PI), a fluorescent dye selectively accumulated by
dying and dead neurons in organotypic brain slices [48,49], or
pooled for immunoblot analyses.
PI staining for assessment of neurodegeneration in HEC
slices
Media were removed from the wells and slices were incubated
for 20–30 min with 1.2 ml fresh serum-free media containing
10 mM PI. After removal of PI-containing media, slices were
washed twice with serum-free media, followed by addition of
complete media with 20% HS for 1 hr before observing
fluorescence results of PI labeling.
Immunoblotting with rat brain tissues
For HNE- and 3NT-proteins in brain regions of binge ethanol-
treated and control rats and in pooled HEC slices, isolated brain
regions or slices (rinsed with phosphate-buffered saline (PBS) and
pooled—6-9 slices) were lysed in an isotonic buffer (50 mM Tris,
1 mM EDTA, protease and phosphatase inhibitor cocktail,
pH 7.4), and then centrifuged for 10 min @ 13,000 rpm. For
the neuroinflammation-associated proteins (cPLA2, p-cPLA2,
sPLA2, iPLA2, AQP4, PARP-1), isolated brain regions or slices
as above were sonicated 15–20 sec in a different lysis buffer (0.1%
SDS, 1% sodium deoxycholate, 1% triton X-100, 150 mM NaCl,
and 25 mM Tris HCl, pH 7.6) containing protease and phospha-
tase inhibitor cocktail. After centrifugation as above, protein
concentrations were acquired with a bicinchoninic acid (BCA)–
based method (Pierce Biotech, Rockford, IL); Aliquots (10 mg
protein) of supernatants were then separated by 12% SDS-PAGE,
transferred to PVDF-immobilon membranes, and subjected to
immunoblot analysis by using appropriate protein antibodies. The
intensities of immunoblots were normalized to GAPDH immuno-
blots, obtained on the same gels following stripping and reprobing,
after scanning images with LABwork 4.5 image acquisition and
analysis software (UltraViolet Products, Upland CA).
Unsaturated fatty acid assay
Lipids were extracted in the presence of internal standard (IS),
tricosanoic acid (23:0), following established procedures in the
Kim laboratory [50]. Aliquots were transmethylated by reaction
with BF3-methanol (14%, w/v) at 100uC for 2 h under nitrogen,
and the methyl esters were then extracted with hexane and
analyzed by gas chromatography-flame ionization detection.
Individual fatty acids were identified by comparing retention
times with known fatty acid standards (GLC-411 from Nu-Chek
Prep., Elysian MN, USA). After comparing peak areas to IS in the
conventional way, the contents of individual fatty acids were
expressed as percent of total identified fatty acids [50].
Statistical analyses
Unless indicated otherwise, results were reproduced with 6–15
brain slices per group in each experiment. Quantitation of PI
fluorescence with 1.99 NIH Image J software was as previously
described in detail [33]. For the protein extracts of both in vivo
brain regions and HEC slices, immunoblot levels were determined
relative to levels of GAPDH as housekeeping protein, and
expressed as percent of control (mean 6 sem). Results were
analyzed for statistically significant differences (p,0.05 or p,0.01)
by Tukey’s t-test and one-way analysis of variance (ANOVA) with
completely randomized design.
Results
In vivo study
Figure 1 confirms the presence of substantial oxidative stress,
i.e., 4HNE-adducted proteins that arise from peroxidation of
endogenous/released AA and adduction of the peroxidative
aldehyde product, 4HNE, with protein sidechains [51], in two
susceptible brain regions in vivo (Majchrowicz rat model) after 4
days of repetitive ethanol gavages and morning sacrifice on day 5.
It is very likely that the large immunoblots in the range of 50–55
KDa for both regions and also ,70+ KDa in EC constitute not
just single proteins but an appreciable number of 4HNE-adducted
proteins, based on 2-dimensional gel studies with such adducts
[52]. When all discernible 4HNE-immunoblots are combined in
the quantitation, significant elevations in levels of 4HNE-adducted
oxidative footprints in HC and EC are observed, consistent the
reported effectiveness of antioxidants in reducing neurodegener-
ation in this in vivo model [53].
Figures 2 and 3 are representative immunoblots of the
neuroinflammation-associated proteins—cPLA2, p-cPLA2,
sPLA2, iPLA2, AQP4 and PARP-1—and their in vivo levels,
normalized to GAPDH, in five brain regions of adult male rats
after neurotoxic binge ethanol or control treatments. Figure 2A
shows that levels of cPLA2 and its phosphorylated/activated form,
p-cPLA2, were significantly increased 40–140% above controls in
the three regions that sustain appreciable neurodegeneration in
Ethanol, Brain Neuroinflammation and DHA
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the model—HC, EC and OB [8]. In contrast, cPLA2 and p-
cPLA2 levels did not differ from control values in the CB and FC,
two regions typically having little or no neurodamage. In Fig. 2B,
the regional changes in sPLA2 mirrored cPLA2—significant
elevations ranging from 75% to 240% above control levels in
the three vulnerable regions of HC, EC and OB, but no significant
changes in CB or FC. Figure 2C shows that iPLA2 was affected
differently by binge ethanol treatment, being significantly reduced
35% below control values in the HC. It was not appreciably
changed from control values in the other brain regions.
Figure 3 shows that in vivo responses to neurotoxic ethanol
binging for AQP4 and PARP-1 mirrored those of cPLA2, p-
cPLA2 and sPLA2. As with the cPLA2 and sPLA2 families,
ethanol binges significantly increased AQP4 levels 65–110%
above controls in the HC, EC and OB, whereas levels of the
water channel did not differ from controls in the CB and FC. As
shown in Figure 3B, PARP-1 also corresponded with the AQP4,
Figure 1. Effects of binge ethanol exposure on oxidative stress (4HNE-) protein footprint levels in vivo. Significant increases over
respective controls (Cont) in levels of oxidative stress footprint, 4-hydroxynonenal (4HNE)-adducted proteins, in hippocampus (HC) and entorhinal
cortex (EC) following neurotoxic binge ethanol treatment of adult male rats for 4 days (Majchrowicz model). Top: representative immunoblots of
4HNE-adducted proteins in HC and EC. Bottom: quantitation of immunoblots of 4HNE-adducted proteins in HC and EC. *p,0.01 vs. control (Cont);
n = 4–7 rats per group.
doi:10.1371/journal.pone.0101223.g001
Ethanol, Brain Neuroinflammation and DHA
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cPLA2, p-cPLA2 and sPLA2 results. Quantitation of PARP-1
immunoblots revealed significant elevations of 125–150% above
controls in the neurovulnerable regions of HC, EC and OB, but
there were no changes in its levels in CB and FC.
In vitro studies
Figure 4, Figure 5 and Figure 6 demonstrate the effects in the
rat adult-age HEC slice cultures of binge ethanol exposure on key
neurotoxic outcomes, the above neuroinflammation-associated
enzymes, and specific unsaturated fatty acid levels, and moreover,
the effects of DHA supplementation on these measures. Figure 4A
(top) shows representative images of HEC slices from control,
DHA (25 mM), ethanol and ethanol+DHA groups at the 3 day
treatment timepoint showing intensified PI labeling of degenerat-
ing neurons due to binge ethanol, and the relative absence of PI-
stained neurons in the ethanol+DHA co-treated slice. The bottom
graph shows that DHA concentrations of 25 and 50 mM potently
inhibit binge ethanol-induced PI labeling (degenerating neurons),
and to approximately the same extent. In Figure 4B, the
quantitation of the time course of PI-stained neurons over 4 days
of binge ethanol treatment demonstrates that degenerating neuron
levels rose significantly above control levels on day 2, and
continued to moderately increase for the two remaining days. The
co-presence of DHA effectively prevented the increased neurode-
generation in HEC slices on each of those three ethanol exposure
days. Although not used in these DHA experiments, adrenic acid,
an analogous 22-carbon n-6 fatty acid and a negative control
which was previously added to HEC slice cultures in place of
DHA, had no effect on binge ethanol-dependent neurodegener-
ation [33].
In Figure 4C the results show that binge ethanol treatment of
the HEC slice cultures for 4 days significantly augmented oxidative
stress as indicated by elevations above basal levels in 3NT-proteins
derived from reactions of peroxynitrite (product of the free
radicals, superoxide and nitric oxide) with proteins. As with the
Figure 1 oxidative protein footprints, the large immunoblots
contain a number of proteins with nitrotyrosine sidechains that
react to antibody, and quantitation encompassed all observable
immunoblots. Consistent with its effects on neurodegeneration, co-
exposure of ethanol-binged slices with DHA (25 mM) largely
abolished elevations in this oxidative footprint. Parenthetically, we
found that HNE-adducted proteins as in the in vivo brain samples
could not be reliably determined in the slices because of
interference from aldehydic adducts derived from supplemented
DHA.
Figure 5 displays the immunoblot levels of five of the six
neuroinflammation-related proteins (i.e., in Figures 2 and 3) in
adult-age HEC slice cultures that were binge-exposed for 4 days to
ethanol (100 mM) or control media, with and without DHA
supplementation. AQP4 augmentation by binge ethanol in these
Figure 2. Selective effects of binge ethanol exposure on brain PLA2 levels in vivo. Significant alterations compared to respective controls
(C) in protein expression (immunoblots) of PLA2 enzymes in brain regions selectively incurring neurodamage due to binge ethanol (E) treatment in
adult male rats for 4 days (Majchrowicz model). Fig. 2A: Significantly increased levels of cPLA2 (top) and p-cPLA2 (bottom) in the hippocampus (HC),
entorhinal cortex (EC) and olfactory bulb (OB), but not in cerebellum (CB) and frontal cortex (FC). Fig. 2B: Significantly increased sPLA2 levels in the
HC, EC and OB, but not in CB and FC. Fig. 2C. Significantly decreased levels of iPLA2 in the HC. *p,0.05 vs. C. **p,0.01 vs. C. n = 4–7 rats/group.
doi:10.1371/journal.pone.0101223.g002
Ethanol, Brain Neuroinflammation and DHA
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Figure 3. Selective effects of binge ethanol exposure on brain AQP4 and PARP-1 levels in vivo. Significant elevations over respective
controls (C) in levels of AQP4 and PARP-1 in those brain regions selectively incurring neurodamage due to binge ethanol (E) treatment in adult male
rats for 4 days (Majchrowicz model). Fig. 3A: Significantly increased AQP4 levels in the HC, EC and OB, but not in CB and FC. Fig. 3B: Significantly
increased PARP-1 levels in the HC, EC and OB, but not in CB and FC. *p,0.05 vs. C. n = 4–7 rats/group.
doi:10.1371/journal.pone.0101223.g003
Ethanol, Brain Neuroinflammation and DHA
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Figure 4. Effects of binge ethanol treatment and DHA supplementation on neurodegeneration and oxidative (3NT-) protein
footprints in adult-age HEC slice cultures. Binge ethanol treatment of adult-age rat HEC slice cultures for 4 days as described in Methods
significantly increases degenerating neurons (PI staining) and the levels of oxidative stress footprints (3NT-proteins), and supplementation of cultures
with DHA prevents the increases. Fig. 4A: (top) Representative PI-stained images showing increased neurodegeneration after 3 days of binge ethanol
treatment (100 mM), with DHA supplementation (25 mM) suppressing PI staining (neurodegeneration). (Bottom) Quantitation of PI labeling shows
significant neurodegeneration due to 4 days of binge ethanol exposure (E), and neuroprotection against E by DHA at 25 and 50 mM. **p,0.01 vs. C.
#p,0.05 vs. E. Fig. 4B. Quantitation of PI labeling reveals significantly increased neurodegeneration over control due to binge E as early as 2 days of
binge ethanol treatment, with prevention of the neurodegeneration throughout the 4 days of treatment by DHA supplementation. *p,0.05 vs.
control (C) or E+DHA. Fig. 4C (Top) Representative immunoblots of 3NT-proteins in HEC slice cultures following binge ethanol exposure (100 mM) for
4 days. (Bottom) Quantitation of immunoblots showing that binge ethanol exposure causes increased 3NT-proteins in the HEC slice cultures, and
DHA supplementation (25 mM) prevents the increases. *p,0.05 vs. Control.
doi:10.1371/journal.pone.0101223.g004
Ethanol, Brain Neuroinflammation and DHA
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adult-age slice cultures and suppression by added DHA were
previously communicated [30]. Here it is evident that neurotoxic
binge ethanol treatment caused significant elevations (160–240%
above controls) in levels of cPLA2 (Figure 5A) and p-cPLA2
(Figure 5B), the latter confirming cPLA2 activation. Whereas
added DHA alone had no effects relative to controls, its
supplementation throughout ethanol treatment prevented increas-
es in both proteins. Similarly, in Figure 5C, HEC slice sPLA2
levels were potentiated ,150% above controls by the binge
ethanol exposure; as with cPLA2, added DHA only did not change
sPLA2, but supplementation abolished ethanol-induced sPLA2
elevations. With iPLA2 (Figure 5D), consistent with in vivo HC
results in Fig. 2C, its levels in the HEC slices were significantly
reduced ,65% by binge ethanol. DHA alone had no effect on
iPLA2 levels, but its supplementation with binge ethanol
countered the reduction in iPLA2, thus normalizing its levels. In
Figure 5E, also coinciding with in vivo findings, PARP-1 levels
were significantly enhanced ,130% over control values by the
binge ethanol exposure. DHA alone did not alter PARP-1 levels,
but consistent with DHA’s PLA2 and AQP4 suppression and its
prevention of neurodegeneration (Figure 4), co-treatment with the
n-3 fatty acid nullified binge ethanol’s potentiation of PARP-1
levels.
Figure 6 shows quantitative results of assays of selected
endogenous long-chain unsaturated fatty acids in lipid extracts of
the binge ethanol-exposed adult rat HEC slices, with and without
DHA supplementation. Expressed as percent of total fatty acids,
endogenous brain content of DHA (22:6n23) was significantly
Figure 5. Effects of binge ethanol treatment and DHA supplementation on PLA2 and PARP-1 levels in adult-age HEC slice cultures.
Significant neuroinflammatory enzyme alterations compared to control (C) caused by 4 days of binge ethanol (E) treatment (100 mM) of adult-age rat
HEC slice cultures, and prevention of the alterations by supplementation of cultures with DHA (25 mM). Fig. 5A: Increased levels of cPLA2 GIVA over
control levels due to binge E and inhibition of the increase by DHA supplementation (E+ DHA). *p,0.05 vs. C; #p,0.05 vs. E. Fig. 5B: Increased levels
of p-cPLA2 GIVA over control levels due to binge E and inhibition of the increase by DHA supplementation (E+DHA). *p,0.05 vs. C; #p,0.05 vs. E.
Fig. 5C: Increased levels of sPLA2 GIIA over control levels due to binge E and inhibition of the increase by DHA supplementation (E+DHA). *p,0.05 vs.
C; #p,0.05 vs. E. Fig. 5D: Reduced levels of iPLA2 GVIA with respect to control levels due to binge E and partial blockade of the reduction by DHA
supplementation (E+DHA). *p,0.05 vs. C. Fig. 5E: Increased levels of PARP-1 over control levels due to binge E and inhibition of the increase by DHA
supplementation (E+DHA). *p,0.05 vs. C; #p,0.05 vs. E.
doi:10.1371/journal.pone.0101223.g005
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depleted by ethanol exposure, and supplementation with DHA
(25 mM) prevented the depletion—results agreeing with earlier in
vivo findings in the Kim laboratory. Concomitantly, binge ethanol
treatment significantly increased a likely DHA precursor, 22:5n2
3, with DHA supplementation promoting a normalization of this
fatty acid’s contents.
Interested in the possibility that PARP-1, known to be activated
by oxidative stress and DNA strand breaks, could have direct
upstream actions on ethanol-induced neurodegeneration in the
adult-age organotypic HEC slices, we used the relatively specific
PARP-1 inhibitor PJ-34 [54] at 10 mM for the initial assessment.
In Figure 7 (upper) are representative images of HEC slices
showing increased PI staining (neurodegeneration) after 4 days of
binge exposure to ethanol (100 mM) without PJ-34, and apparent
suppression of fluorescence by PJ-34 co-administration. Quanti-
tation in Figure 7 (lower) of fluorescence verified significant
neurotoxicity in ethanol-binged slices, and while PI staining with
PARP-1 inhibitor PJ-34 alone was not different from controls, its
co-presence exerted significant neuroprotection against the etha-
nol-induced neurotoxicity.
Discussion
We demonstrate with age-complementary in vivo and in vitro
adult rat brain models that major neuroinflammation-associated
pro-oxidative pathways encompassing AQP4, key PLA2 families,
and PARP-1 are significantly altered in binge ethanol-dependent
neurodegeneration. Specifically, neurotoxic ethanol binging pro-
motes significant elevations in cPLA2, p-cPLA2, and sPLA2 and
decrements in iPLA2 in both models. The in vivo results with the
well-documented ‘‘Majchrowicz’’ binge model [6] were distin-
guished by the fact that, along with AQP4 and PARP-1, the above
PLA2 elevations occurred in three brain regions that typically
sustain neurodegeneration, but not in two regions having few if
any degenerating neurons. In adult-age rat organotypic HEC slice
cultures the ethanol-induced changes in these neuroinflammation-
linked proteins agreed well with the in vivo findings, and
furthermore, were in accord with recent binge ethanol results in
vivo [45] in that the neurodegeneration becomes manifested
within a few days of exposure. Whether the above proteins
constitute a relatively unified cohesive pathway or are components
of interacting, even redundant, signaling routes for induced
oxidative neurodamage is yet to be established; however, the
results (Figure 7) with a PARP-1 inhibitor provide preliminary
evidence implicating a PARP-1-contingent neurotoxic process.
The results further indicate that supplementation with an essential
n-3 fatty acid, DHA—previously reported to halt ethanol-
engendered neurodegeneration in binge-treated brain slices—
additionally suppresses alterations in the neuroinflammatory
proteins and oxidative stress footprints.
Among the proteins examined, AQP4 is of particular interest, as
research principally with ischemic or traumatic brain damage
models, but also with water intoxication and certain brain
infections, demonstrates that increased activity or levels of the
astroglial water channel regulates cytotoxic (cellular) brain edema
[17,55]. Astroglial overexpression of AQP4 in mice accelerates
ischemia-induced brain edema [56], and AQP4 knockdown in
traumatized astroglial cultures reduces cell swelling [57]. AQP4
may have a prominent neuroinflammatory role in brain insults,
since experiments with AQP4 knockout mice confirm the protein’s
requirement for full induction of brain proinflammatory cytokines
(notably tumor necrosis factor alpha) during endotoxin treatment
or experimental allergic encephalomyelitis [58]. Thus AQP4 acts
as a brain neuroinflammatory channel during particular stresses or
insults.
Figure 6. Effect of binge ethanol treatment and DHA supplementation on contents of DHA and selected unsaturated fatty acids in
adult-age HEC slice cultures. Binge ethanol treatment (EtOH, 100 mM) of adult-age rat HEC slice cultures for 4 days as described in Methods
significantly decreases the slice content of endogenous DHA (22:6n23); supplementation of ethanol-binged cultures throughout with 25 mM DHA
normalizes the DHA content. Binge ethanol treatment also increased the endogenous content of 22:5n23, and DHA supplementation reduced the
levels of this potential DHA precursor, as well as reduced the endogenous levels of ARA (22:4n26). All other unsaturated fatty acids (not shown) were
not significantly changed by binge ethanol treatment and DHA supplementation. *p,0.05 (n = 3/group, Tukey’s t-test).
doi:10.1371/journal.pone.0101223.g006
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After finding moderate brain edema in a once-daily adaptation
of the Majchrowicz ethanol gavage model, we determined that
edema’s deterrence with furosemide in that model and in ethanol-
binged HEC slice cultures was neuroprotective [11]—as it was
with the diuretic, acetazolamide [12], which fortuitously is an
AQP4 inhibitor. Astroglial cells in culture swell due to ethanol
exposure and withdrawal, but previous evidence of blockade by
diuretics has been conflicting [59,60]. However, acceleration of
trauma-related cerebral edema by ethanol has been linked to
increased AQP4 upregulation and activity, with acetazolamide,
presumably through inhibition of AQP4, exerting protection [61].
Herein, binge ethanol-induced AQP4 elevations in brain regions
that sustain neurodegeneration, but not in regions known to lack
neurodamage, indicate that the water channel could be an
important factor in the regioselective neurodegeneration. Further-
more, increased AQP4 in the binge-treated adult-age HEC slice
cultures, as well as being in accord with in vivo results, is in
harmony with our findings in developing HEC slice cultures [12].
How AQP4 levels are altered by ethanol binges requires study, but
several stimuli known to potentiate brain or astroglial AQP4
levels/activity are reported by others to be increased by ethanol in
various exposure protocols. For example, ROS [62], lactic acid
[[63], proinflammatory cytokines [64], and glutamate [65] have
been shown to increase the water channel. Depending on the
model, ethanol and/or ethanol withdrawal can promote or
potentiate brain levels of all of these factors [9,66,67].
PLA2 isoforms, and chiefly those of Ca+2-dependent cPLA2 and
sPLA2 families, are rate-controlling for normal or excessive release
of ARA. This essential n-6 fatty acid is precursor for neuroin-
flammatory eicosanoids as well as ROS generation via subsequent
action of cyclooxygenases and/or autooxidation. Interestingly, a
feed-forward mechanism could also operate, since ARA-derived
eicosanoids (leukotrienes) can increase AQP4 and promote edema
[68]. Of the two PLA2 families, cPLA2 (,85 kDa) and its
hyperactivation have been most frequently linked to AA-derived
neuroinflammation and neurodegeneration [20,69]. Furthermore,
PLA2 isoforms are prone to be increased and/or activated by
brain cell swelling and deformation [18], and cPLA2 can act as
a mechanosensitive transducer to cellular osmotic stress and
membrane stretching [70,71]. Also, phosphorylation by mitogen-
activated protein kinase (MAPK) family members, a catalytic step
producing activated p-cPLA2, is similarly modulated by osmotic
or stretch-induced stress [72,73], which is entirely compatible with
the mechanisms in these binge ethanol models.
The smaller sPLA2 family members (13–20 KDa), either
independently or complicit with cPLA2, could be involved in
brain neuroinflammatory mechanisms [74]. Notably, inhibition of
sPLA2 has been found to reduce neuroinflammation and ischemic
injury in adult rats [75]. Brain sPLA2 IIA elevations have been
documented in rat stroke models [76], during Alzheimer’s disease
[77], and now in the acquired brain damage caused by binge
ethanol in organotypic brain slice cultures. However, other sPLA2
family members such as sPLA2 V and most recently sPLA2 III,
expressed intraneuronally in synaptic regions [78], also could be
important in ethanol’s mechanism and should be investigated. It
has been known for some time that chronic ethanol in vivo
increases brain PLA2 activity in general [79], so at this juncture it
is plausible to consider that the elevated cPLA2 and sPLA2
Figure 7. Effect of PARP-1 inhibitor PJ-34 on ethanol-induced neurodegeneration in adult-age HEC slice cultures. Neurodegeneration
(PI staining) due to 4 days of binge ethanol treatment (100 mM) of rat adult-age organotypic HEC slice cultures is suppressed by co-treatment with
PARP-1 inhibitor, PJ-34 (10 mM). (Top) Images of representative PI-stained slices from C, PJ-34, E and E+PJ-34 slice cultures indicate increased
neurodegeneration (E) that is reduced in E+PJ-34. (Bottom) Quantitation of PI staining demonstrates increased neurodegeneration due to binge
ethanol (E) that is significantly suppressed by PJ-34 (E + PJ-34). **p,0.01 vs. C. ##p,0.01 vs. E.
doi:10.1371/journal.pone.0101223.g007
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activities are components of downstream neuroinflammatory
activation and ROS increases during binge ethanol exposure.
Furthermore, the observed reduction in iPLA2 GVI levels due
to ethanol is in harmony with neuroinflammatory outcomes that
indicate a reciprocal relationship between iPLA2 and cPLA2/
sPLA2 [80,81]. This could relate to iPLA2 possibly serving as a
mitochondrial housekeeping and protective enzyme [22]. Studies
have associated iPLA2 with suppression of lipid peroxidation [82],
and such an anti-oxidant function could be explained by the
enzyme’s activity in sustaining endogenous DHA turnover in brain
membrane phospholipids [83]. Reduced DHA turnover related to
iPLA2 depletion in binge ethanol-exposed brain could portend
diminished endogenous neuroprotection associated with this n-3
fatty acid (discussed in more detail below).
Binge ethanol’s significant potentiation of multi-faceted PARP-1
selectively in vivo as well as in HEC slices, in concert with a
PARP-1 inhibitor’s suppression of neurodegeneration (and also
our previous report with a relatively moderate binge rat model for
robust PARP-1 augmentation [23]), support a role in ethanol
neurotoxicity for this previously underappreciated player. Nuclear
PARP-1 responds to oxidative stress and DNA strand breaks to
synthesize polyADP-ribose (PAR) chains that then recruit DNA
repair protein assemblies. However, PARP-1 hyperactivation can
deplete essential cellular NAD+ levels and ATP, as well as trigger
PAR-directed mitochondrial non-apoptotic death, which is termed
parthanatos [24]. Parthanatos is a probable neuronal death
pathway in a transgenic Parkinsonian mouse model [84] and in
endotoxin-induced neuroinflammation [85]. To our knowledge,
PARP-1-dependent neuronal demise has not been linked con-
vincingly to ethanol, nor has the enzyme been experimentally
associated with brain AQP4- or PLA2-dependent neuroinflam-
matory pathways. However, a functional link between PARP-1
activity and binge ethanol neuropathology as indicated by PJ-34
inhibitor results (Figure 6) is consistent with elevated brain
oxidative stress in chronic ethanol-treated rodents [9], oxidative
DNA damage in brain of alcoholics [86], and—in regard to
parthanatos—the absence of neuronal apoptosis (i.e., predomi-
nance of necrosis) in the Majchrowicz binge ethanol model [10].
Future experiments with the binge models should employ RNA
interference and other inhibitors together with PAR measure-
ments in order to more firmly establish PARP-1’s role in binge
ethanol-induced neurodegenerative signaling.
The prominent actions of supplemented DHA in the adult HEC
slices may provide insights into neuroinflammatory protein
mechanisms in the binge ethanol models. Growing evidence
indicates that DHA administration during other neurodamaging
conditions or diseases can promote prosurvival and/or neuropro-
tection [87,88]. The data herein show that DHA supplementation
of binge ethanol-treated HEC slice cultures inhibits elevations in
the selected PLA2 families, PARP-1, and as reported, AQP4 water
channels [30], concomitant with inhibiting neurodegeneration. To
be noted is that DHA’s suppression of these neuroinflammatory
pathways in vitro is highly consistent with protective findings
previously reported with the Majchrowicz binge intoxication
model—(1), with furosemide, a diuretic having anti-oxidative and
potentially anti-inflammatory effects [89]; (2) with cannabidiol, an
anti-inflammatory compound that also exerts neuroprotection
[89]; and (3) with metabotropic glutamate receptor stimulation,
which selectively elevates transforming growth factor-b (sup-
pressed by the binging) and inhibits entorhinal cortex neurode-
generation [90].
We consider that two overall neuroprotective mechanisms for
DHA in the experimental literature could be functioning. The first
advances that enriched esterification in the 2-position of
phospholipids with DHA, and in particular, inner neuronal
membrane phosphatidylserine, sustains neuronal survival against
insults. In part such phosphatidylserine enrichment with DHA
favors translocation and activation of PKB/Akt, a key pro-survival
kinase that antagonizes oxidative signaling [91,92]. Indeed, as
Figure 6 demonstrates, gas chromatography assays of the HEC
slice cultures reveal relatively selective reductions in endogenous
DHA levels from binge ethanol treatment, with restoration by
supplemented DHA.
A second mechanism relates to unesterified or ‘‘free’’ DHA and
its metabolic products. Considerable attention has focused on
DHA’s dihydroxylation initiated by 15-lipoxygenase-1 to generate
10R,17S-dihydroxydocosa-4Z,7Z,11E,13E,15Z,19Z-hexaenoic ac-
id or neuroprotectin-1 (NPD1); other oxidized isomers, inclusively
termed resolvins, also may be produced via this or a related enzyme
[93,94]. NPD1, formed primarily in brain astroglia from DHA, is a
highly potent cytoprotectant and antioxidant against retinal and
brain ischemic insults, and can suppress brain neuroinflammation
[95]. Another potentially neuroprotective product of nonesterified
DHA that has received recent attention is amidated docosahex-
aenoylethanolamide (synaptamide) [96], which is structurally
analogous to the arachidonic acid-derived cannabinoid, arachido-
noylethanolamide (anandamide). Synaptamide has been shown to
promote neurite growth and preserve synaptic function [97], and it
is tenable that it, like the hydroxylated DHA derivatives, NPD1 and
other resolvins, might wield antioxidant-related neurosurvival
effects.
Integrating our findings within a mechanistic scheme, the
speculation is that the first ethanol binges trigger limited but still
effectual increases in ROS primarily during withdrawals (or its
nadirs in vivo), somewhat akin to ischemia-reperfusion. Possible
ROS sources include NADPH oxidase stimulation, ethanol
metabolism (cytochrome P450, catalase, peroxidases), and/or
mitochondrial membrane damage/leakage. Such early ROS
generation could be sufficient to boost AQP4 expression via
unspecified oxidative transcription factors, while also initiating
nuclear DNA fragmentation and thus enhancing upregulation of
PARP-1. Repetitive binges would greatly augment these events,
leading to astroglial swelling-related activation/expression of
cPLA2 and sPLA2, which evoke excessive AA mobilization, loss
of endogenous DHA turnover due to decreased iPLA2, and
greater increases in neuron-damaging ROS levels, concomitant
with PAR-mediated glial activation [54] and associated partha-
natos.
Supplemented DHA, exerting anti-oxidant actions through
routes outlined above, could overcome immediate ROS genera-
tion triggered by the first several ethanol binges and basically
inhibit the cascade of downstream ROS-augmenting cascades that
depend upon PARP-1, AQP4, and PLA2. Relevant to this scheme
is that DHA co-treatment in a DNA alkylating agent-treated
hippocampal cell line blocks PARP-1 activity (PAR formation)
while preventing oxidative stress and neuronal death [98]. In view
of PET neuroimaging results indicating DHA metabolic deficits
in brains of chronic alcoholics [99], our DHA findings in vitro
reinforce an implication from that report that n-3 fatty acid
supplementation during withdrawal therapy could be beneficial for
cognitive support and even neuroprotection. Indeed, enrichment
of neuronal cell phospholipids and particularly phosphatidylserine
with supplemental DHA has been known for some time to effect
neuroprotection against a range of insults [100].
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